Intercept Pharmaceuticals reported $-17284000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Amarin AMRN:US $ -31.56M 46.26M
Amgen AMGN:US $ 1476M 423M
Arrowhead Research ARWR:US $ 44.37M 107.24M
AstraZeneca AZN:LN 386M 733M
Biogen BIIB:US $ 303.8M 64.4M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.48M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Galectin Therapeutics GALT:US $ -9.93M 2.71M
Gilead Sciences GILD:US $ 19M 363M
GlaxoSmithKline GSK:LN 1802M 1053M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Moderna Inc MRNA:US 3.66B 1.21B
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NOVN:VX SF 2222M 14086M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
YTE INCY:US $ 37.99M 525.86M